Update on PET/CT in autoimmune disorders.
(2022) The Quarterly Journal of Nuclear Medicine and Molecular Imaging — Vol. 66, n° 3, p. 179-181 (2022)
Files
2022_Leccisotti_Q_J_Nucl_Med_Mol_Imaging.pdf
Open Access - Adobe PDF
- 281.41 KB
Details
- Authors
- Abstract
- Inflammation is involved in a wide variety of disorders including malignancy, infection and auto-immune diseases, and imaging-based inflammation is nowadays frequently used for timely diagnosis and monitoring of treatment response. Following the clinical introduction of stand-alone positron emission tomography (PET) using 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) in the 1970’s with the initial intent to explore applications in the central nervous system, and after technological advances in detector material making whole-body scanning possible, the first applications of [18F]FDG/PET for imaging tumors and inflammation arose in the mid-1990s. [...]
- Affiliations
Citations
Leccisotti, L., & Gheysens, O. (2022). Update on PET/CT in autoimmune disorders. The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 66(3), 179-181. https://doi.org/10.23736/S1824-4785.22.03471-9 (Original work published 2022)